| |
|
|
The
High Cost of Quality Science
Doing
biology or chemistry -- or any other science -- these days almost
always requires sophisticated laboratories and multi-million-dollar
equipment. Faced with the possibility of massive cuts in government
funding, Yale researchers are coming up with new ways to close the
cost gap.
April
1996
by Bruce Fellman
When
Margaret
"Peg" Riley, an evolutionary biologist, came to Yale
in 1991, the cost of purchasing the centrifuges, spectrophotometers,
test tubes, and the like that her research required came to roughly
$200,000. The
University picked up the tab -- and then some. Her workspace in
the venerable Osborn Memorial Laboratories had just been overhauled
as part of a $3.1 million renovation. And to help launch her research
career, her department gave her a light teaching load for her first
few years on the faculty. "The junior people are really sheltered
to give them a head start," she says.
In an era of multi-billion-dollar
"big science" projects, the cost of getting Riley into
the research business might not seem like much -- until one compares
it with the tariff associated with outfitting a humanities scholar,
who often needs little more than office space, a word processor,
and access to a library. Science, even relatively small-scale work
like Riley's, is increasingly expensive. The tools of the modern
scientific trade tend to be exotic, and costly. So costly, in fact,
that Yale officials expect to spend an average of $300,000 to attract
a junior faculty member in the sciences to Yale; equipping a laboratory
worthy of a senior-level scientist can exceed $2.5 million.
In the past, federal
funding agencies such as the National Science Foundation and the
National Institutes of Health made it possible to look at these
up-front costs as a kind of long-term investment: Good science -- and
scientists -- attracted grants, and this money often more than made
up for any initial expenses.
In Peg Riley's case,
for example, the fact that she walked into an up-and-running lab
enabledher to start generating research results immediately, and,
because she had time to seek out grants instead of teaching, Riley
could turn her data into proposals for funding. "Yale's support
provided me with access to opportunities," she says.
Riley's science did
the rest and has garnered sufficient funds, largely through the
NSF, to carry her until the year 2000. Nor is her experience unique
at Yale. A substantial amount of money flows through the Washington
pipelines, says theoretical physicist Pierre Hohenberg, deputy provost
for science and technology. During the last fiscal year, direct
and indirect support for research brought $269 million to Yale.
While the majority of the grant money was awarded to scientists
at the Medical School, almost $64 million came to researchers on
the Faculty of Arts and Sciences. This figure represents, says Hohenberg,
22 percent of FAS income. "The only thing that brings in more
money is tuition," he notes.
But some members of
Congress are proposing massive cuts in federal support for the kind
of basic research practiced by academic investigators, and while
no one can predict precisely what kind of budget will emerge, scientists
at Yale and around the country are looking for ways to cope with
what everyone expects will be a decline in support. At the University,
this predicament arrives in concert with another high-cost problem.
"Our standing in the research community is in many cases hampered
by our facilities," says Hohenberg.
To be
sure, Science Hill is home to some superb labs.
There's the $35 million Nancy Lee and Perry R. Bass Center for Molecular
and Structural Biology, which was completed in 1993 and is clearly
an example of that overused term, "state-of-the-art."
In addition, recent renovations of parts of the Osborn, Kline Chemistry,
and J. Willard Gibbs buildings have brought the refurbished sections
up to scientific muster. But this work, says Hohenberg, is just
the beginning, and at present, he and a team of administrators and
researchers are developing a master rehabilitation plan that may
cost an estimated $200 million and take ten years to complete.
"We're determined
to go beyond simply keeping the engine running," Hohenberg
says. "We're making a major commitment designed to significantly
improve things, particularly in chemistry, forestry and environmental
science, and biology."
There is already an
effort in the works to create an environmental science center in
conjunction with the Peabody Museum of Natural History and Yale's
Institute for Biospheric Studies.
And although at least some of the scientists who reside in the Kline
Biology Tower have called for abandoning the building in favor of
a new structure that better meets their needs, a program of extensive
renovations to KBT is currently underway.
Some Science Hill buildings
can be made to work, but others have simply outlived their usefulness.
The Forestry School's Greeley Laboratory needs to be replaced, says
Hohenberg, and among the options under consideration is renovating
the rest of Osborn and moving forestry research there, or building
a new facility.
The neo-Gothic Sterling
chemistry lab, however, is an example of a building that, though
still sturdy enough, was designed for a breed of science that time
has passed by. "The fate of Sterling is up in the air,"
says Hohenberg, who explains that while planners have come up with
"a broad spectrum of scenarios, all of which are, at the moment,
feasible," a likely strategy for improving chemistry involves
both the renovation of the 1960s-vintage Kline chemistry lab and
new construction.
But bricks
and mortar are only part of the story.
Equipping a laboratory can put a strain on any budget, particularly
these days, when it is no longer possible to assume that federal
grants will, as they have in the past, provide the funds for instrumentation
and upkeep. In this era of uncertainty, Yale has, through a combination
of financial muscle and a willingness to take risks, enabled researchers
like Kurt Zilm, a professor of chemistry, to obtain costly equipment
that instantly makes the University number-one in a particular area
of science. Zilm, and at least half-a-dozen colleagues in chemistry,
physics, molecular biochemistry and biophysics, and the Medical
School, work with what is called nuclear magnetic resonance (NMR)
to dissect and understand the behavior of atoms and molecules.
Researchers at Yale
have used NMR to study everything from the structure of nucleic
acids involved in the genetic code to how thoughts are formed in
the brain. The technology enables Zilm to understand the ways in
which various metals interact with hydrogen, and this study in basic
chemistry has practical applications in such areas as fuel cell
technology, materials science, and drug development.
Pursuing such studies
meant getting a more powerful machine, but money was an object.
However, at the time Zilm began to look into fundraising options,
the National Science Foundation had in place a program that provided
matching grants for equipment. Money from the University helped
attract a considerable amount of foundation and corporate support,
and as a result, the chemist and his colleagues were able to add
to their analytical arsenal not just the one advanced technology
NMR machine they sought, but four NMR instruments, including one
that is in its final stages of development. This 800-megahertz machine,
the first of its kind, will form the core of the University's High-Field
Nuclear Magnetic Resonance Laboratory, a modern facility that occupies
retooled headquarters in the Kline chemistry building.
Zilm, who will direct
the new lab, explains that going after such high-tech -- and high cost -- equipment
was a gamble. But because "Yale understood the risks and was
willing to back us," he says, "we're positioned very well
for the next ten years."
The University was not
always so supportive, notes D. Allan Bromley, dean of engineering.
In fact, science at Yale has suffered as a result of what he calls
"bad decisions" made right after the end of World War
II. "Many of the Ivies, and schools like MIT and Caltech, recruited
scientists from the Manhattan Project and received whole trainloads
of war surplus laboratory equipment," says Bromley. Yale, however,
didn't jump on the research bandwagon. This hesitancy might have
gone on forever, but in the late-1950s, nuclear physicist J. Robert
Oppenheimer was called in to evaluate the University's scientific
prowess. "Oppenheimer told the Corporation that the quality
of science here was appalling and that Yale should be ashamed of
itself," says Bromley.
One way to upgrade would
have been to follow the example set last decade by the University
of Texas, the dean notes. Its science programs were lackluster,
but armed with determination and about $150 million in state funding,
that university "simply bought a bunch of Nobel laureates"
and other scientific superstars, along with the equipment they required.
"Money alone can do the job -- if you have enough of it,"
notes Bromley.
But these days, money
is too tight here to pursue a similar strategy. To cope with the
current funding environment, scientists must be both realistic and
creative.
At Yale, the overall
plan is to concentrate on strengths, while growing only in certain
narrowly defined areas. For example, in engineering, the dean's
focus is to maintain excellence in the department's already-established-and
well-equipped programs in such areas as combustion, microelectronics,
laser diagnostics, and acoustics. "Trying to become MIT makes
no sense at all," says Bromley. Still, he would like to expand
somewhat and add specialties in environmental and biomedical engineering.
But rather than rely on large infusions of cash, these new programs
would take advantage of the "tremendous synergism" at
Yale that enables researchers to cross disciplines and link up with
existing people and equipment.
Another potential way
to bring the high cost of science down is to pursue areas of inquiry
that have money-making potential. "We estimate that Yale research
will generate about $5 million in license fees and royalties in
1996," says Gregory Gardiner, director of the Office of Cooperative
Research, the University's liaison between Yale researchers and
businesses interested in the commercialization of science.
Ironically, perhaps,
there has been an unforeseen benefit to such academic and corporate
relationships. Numerous companies are dismantling substantial portions
of their research facilities, and this trend has created opportunities
to procure what Dean Bromley calls "first-rate instrumentation"
at bargain basement prices. "We've been very adroit at getting
surplus machinery at low-or no-cost," he notes, pointing to
valuable equipment that Yale recently obtained from both Nanometrics
and Amoco. In 1986, Bromley, who served as science adviser to George
Bush '48 and is no stranger to the inner workings of the federal
government, wound up with a NASA cast-off that vastly improved the
University's program in probing the structure of the atomic nucleus.
And while he acknowledges that the prevailing budget-slashing orientation
of Congress may lead to the closing of some of this country's 726
federal laboratories -- a possibility the dean terms "painful" -- Yale
will be first in line for any equipment that becomes available.
"We're prepared to move fast," says Bromley.
Besides developing innovative
funding packages, pushing scientific discoveries in a profit-making
direction, and seeking out high-quality surplus, the University
has found other ways to make science more affordable. One time-honored
method, of course, is to cooperate with other institutions. This
strategy has already resulted in the recently completed WIYN telescope
on Kitt Peak in Arizona. Yale invested $3 million, which gives it
a 17 percent share in the sophisticated instrument, a joint venture
of the University, the National Optical Astronomy Observatory, and
the universities of Wisconsin and Indiana. Because the instrument
will soon be fully accessible from special computer terminals in
New Haven, astronomers won't even have to leave home to view the
heavens.
Because
of computer networks, "where you are is often irrelevant,"
says Sabatino Sofia, chairman of the astronomy department. Sofia's
work, which involves making precise measurements of the changes
in the sun's diameter -- research of key importance to scientists
studying the Earth's climate -- is itself an illustration of the
science-without-borders cooperation that many see increasing in
the future. The astronomer's laboratory is actually located at NASA's
Goddard Spaceflight Center in Greenbelt, Maryland, and Sofia gathers
his data with an instrument he designed for use on high-altitude
balloons launched by NASA in their facilities in the southwest.
In addition to this
sharing of equipment and laboratories, both among departments and
among other research institutions, another certain area of growth
in these challenging times, say scientists and administrators alike,
is putting discoveries and technologies developed for one purpose
to new uses. For example, two years ago, Charles Baltay, chairman
of the physics department, was perfecting instruments known as CCDs,
which were to be used to detect the subatomic particles created
by the Superconducting Supercollider, a giant atom smasher designed
to reveal details about the fundamental nature of matter. The $11
billion project died when Congress eliminated its funding, but Baltay
and Sofia are currently attempting to modify the CCD technology
the physicist devised and use it to search the edges of space for
answers to questions about the age and fate of the universe.
Such surprising utility
is, after all, why basic research, however expensive, continues
to be considered a worthwhile investment. A case in point can be
found in Peg Riley's lab. Her seemingly esoteric studies on the
evolution of self-defense strategies among intestinal bacteria were
sufficiently well funded that the biologist was able to apply her
expertise to a project that, at first glance, appeared to have nothing
whatsoever to do with her specialty. Riley is now working on understanding
and chronicling the emergence of a lethal bacterial strain that
kills people suffering from cystic fibrosis. "My initial research
had no medical relevance," says the biologist, "but what
I've found recently may help cystic fibrosis patients lead longer,
happier lives. Funding pure science can have unexpected results."
|
|